Updates from the HUGO Gene Nomenclature Committee (HGNC) relevant to Human Genomics readers.
Featured article: Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
The field of pharmacogenomics is gradually shifting from the reactive testing of single genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce adverse events, and decrease the burden of unnecessary costs for healthcare systems. Despite the progress in the field of pharmacogenomics, its implementation into routine care has been slow due to several barriers. This review focuses on some of the challenges faced by these initiatives, the solutions and different approaches for testing that they suggest, and the evidence that they provide regarding the benefits of preemptive pharmacogenomics testing.
Articles
-
-
Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening
-
Genetics and functions of the retinoic acid pathway, with special emphasis on the eye
-
Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features
-
Transcriptomic analysis of monocytes from HIV-positive men on antiretroviral therapy reveals effects of tobacco smoking on interferon and stress response systems associated with depressive symptoms
-
Ernst Wit and John McClure John Wiley & Sons Ltd, Chichester, UK, 2004
-
Intragraft transcriptional profiling of renal transplant patients with tubular dysfunction reveals mechanisms underlying graft injury and recovery
-
Survival analysis tools in genomics research
-
Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities
-
Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection
HGNC updates
Previous content
Human Genomics launched with BioMed Central in July 2012, transferring from its previous publisher Henry Stewart Publications. All back content is now available in the archive.
From the Blog
Aims and scope
Human Genomics is a peer-reviewed, open access journal that focuses on the application of genomic analysis in all aspects of human health and disease, as well as genomic analysis of drug efficacy and safety, and comparative genomics.
Call for Papers: Public Health Genomics
Guest Editors: George P Patrinos, University of Patras, Greece; Hongyu Zhao, Yale University, USA
Papers are invited which address current issues in human public health genomics, such as genomic surveillance of disease, genetic risk prediction, individual genome interpretation, gene-environment interactions, genetic diversity of vector-borne disease, vaccination and vaccine-based approaches against pathogens data sharing, economic evaluation in genomic medicine, and the role of big data and artificial intelligence on the development of translational tools and services and the overall future of public health.
Submission Deadline: March 2020
Advertisement
- Editorial Board
- Sign up for article alerts and news from this journal
-
Official journal of
-
Follow
Annual Journal Metrics
-
Speed
42 days first decision for reviewed manuscripts only
33 days to first decision for all manuscripts
90 days from submission to acceptance
14 days from acceptance to publicationCitation Impact
2.544 - 2-year Impact Factor
3.526 - 5-year Impact Factor
0.844 - Source Normalized Impact per Paper (SNIP)
1.632 - SCImago Journal Rank (SJR)Usage
272,691 Downloads
448 Altmetric Mentions
Advertisement
